Samalin Investment Counsel’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $237K | Buy |
+441
| New | +$237K | 0.09% | 278 |
|
|
2024
Q4 | – | Sell |
-566
| Closed | -$286K | – | 313 |
|
|
2024
Q3 | $286K | Sell |
566
-15
| -3% | -$7.58K | 0.12% | 229 |
|
|
2024
Q2 | $283K | Hold |
581
| – | – | 0.13% | 225 |
|
|
2024
Q1 | $314K | Hold |
581
| – | – | 0.15% | 207 |
|
|
2023
Q4 | $322K | Sell |
581
-7
| -1% | -$3.89K | 0.16% | 202 |
|
|
2023
Q3 | $257K | Sell |
588
-3
| -0.5% | -$1.31K | 0.15% | 194 |
|
|
2023
Q2 | $297K | Buy |
591
+2
| +0.3% | +$1K | 0.16% | 179 |
|
|
2023
Q1 | $295K | Hold |
589
| – | – | 0.18% | 166 |
|
|
2022
Q4 | $240K | Buy |
+589
| New | +$240K | 0.15% | 186 |
|
|
2022
Q3 | – | Sell |
-696
| Closed | -$244K | – | 238 |
|
|
2022
Q2 | $244K | Sell |
696
-240
| -26% | -$84.1K | 0.17% | 178 |
|
|
2022
Q1 | $512K | Buy |
936
+31
| +3% | +$17K | 0.31% | 94 |
|
|
2021
Q4 | $596K | Buy |
905
+47
| +5% | +$31K | 0.36% | 79 |
|
|
2021
Q3 | $533K | Buy |
858
+31
| +4% | +$19.3K | 0.35% | 89 |
|
|
2021
Q2 | $523K | Sell |
827
-6
| -0.7% | -$3.79K | 0.34% | 96 |
|
|
2021
Q1 | $407K | Sell |
833
-55
| -6% | -$26.9K | 0.27% | 119 |
|
|
2020
Q4 | $444K | Sell |
888
-219
| -20% | -$110K | 0.33% | 95 |
|
|
2020
Q3 | $435K | Sell |
1,107
-89
| -7% | -$35K | 0.39% | 79 |
|
|
2020
Q2 | $394K | Sell |
1,196
-1,063
| -47% | -$350K | 0.41% | 70 |
|
|
2020
Q1 | $547K | Sell |
2,259
-155
| -6% | -$37.5K | 0.73% | 37 |
|
|
2019
Q4 | $630K | Buy |
+2,414
| New | +$630K | 0.53% | 44 |
|